TUMOUR NECROSIS FACTOR INHIBITORS AND THE RISK OF ACUTE CORONARY SYNDROMES IN RHEUMATOID ARTHRITIS PATIENTS

被引:0
|
作者
Ljung, L. [1 ,2 ]
Askling, J. [2 ]
Rantapaa-Dahlqvist, S. [1 ]
Jacobsson, L. [3 ]
机构
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden
关键词
D O I
10.1136/annrheumdis-2014-eular.2849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0182
引用
收藏
页码:244 / 244
页数:1
相关论文
共 50 条
  • [41] Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor a: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Bruce, Ellen S.
    Kearsley-Fleet, Lianne
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2016, 55 (07) : 1336 - 1337
  • [42] The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis
    Peters, Mike J. L.
    van Sijl, Alper M.
    Voskuyl, Alexandre E.
    Sattar, Naveed
    Smulders, Yvo M.
    Nurmohamed, Michael T.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (11) : 1502 - 1511
  • [43] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [44] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [45] DO TUMOUR NECROSIS FACTOR INHIBITORS INCREASE THE RISK OF HERPES ZOSTER IN PEOPLE WITH RHEUMATOID ARTHRITIS?: A COHORT STUDY
    Segan, J.
    Staples, M.
    Chand, V
    March, L.
    Lassere, M.
    Buchbinder, R.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 6 - 6
  • [46] New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
    Scott, David L.
    Cope, Andrew
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 767 - 769
  • [47] Perforating folliculitis associated with tumour necrosis factor-α inhibitors administered for rheumatoid arthritis
    Gilaberte, Y.
    Coscojuela, C.
    Vazquez, C.
    Rosello, R.
    Vera, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 368 - 371
  • [48] GENETIC INFLUENCE OF DIFFERENT MEASURE FOR TUMOUR NECROSIS FACTOR INHIBITORS RESPONSE IN RHEUMATOID ARTHRITIS
    Bang, S.
    Park, Y.
    Kim, K.
    Joo, Y. B.
    Cho, S. -K.
    Choi, C. -B.
    Sung, Y. -K.
    Kim, T. -H.
    Jun, J. -B.
    Yoo, D. -H.
    Lee, H. -S.
    Bae, S. -C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1211 - 1211
  • [49] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Dentener, Mieke A.
    Wouters, Emiel F. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2047 - 2048
  • [50] Inhibitors of tumor necrosis factor for rheumatoid arthritis
    Moreland, LW
    JOURNAL OF RHEUMATOLOGY, 1999, 26 : 7 - 15